磁共振成像VI-RADS评分在膀胱癌中的应用及进展

Application and progression of magnetic resonance imaging VI-RADS score in bladder cancer

膀胱癌是泌尿系统发病率最高的恶性肿瘤,因对其进行准确的分类及分期较为困难,使膀胱癌患者的诊治面临着诸多问题。随着现代医疗技术的不断发展和完善,2018年,基于多参数磁共振成像(multi-parametric magnetic resonance imaging, mpMRI)技术所提出的膀胱影像报告和数据系统(Vesical Imaging-Reporting and Data System, VI-RADS)得到了日本腹部放射学会、欧洲泌尿外科协会及欧洲泌尿外科影像学会的共同认可。VI-RADS评分可对膀胱癌进行较为准确的分类,为临床医生对膀胱癌患者的治疗提供指导。本文就VI-RADS在膀胱癌中的诊断效能、VI-RADS参数及诊断膀胱癌时最佳临界值的选择、VI-RADS与影像组学的联合等研究现状及进展进行综述,并对肿瘤大小和肿瘤所在部位对VI-RADS的影响等未来研究方向进行展望,旨在为该领域研究提供参考。

Bladder cancer is the most common urinary malignant tumor,because it is difficult to accurately classify and stage it,which makes the diagnosis and treatment of bladder cancer patients face many problems.With the continuous development and improvement of modern medical technology.In 2018,the Vesical Imaging-Reporting and Data System(VI-RADS)based on multi-parametric magnetic resonance imaging(mpMRI)technology has been recognized by the Japanese Society of Abdominal Radiology,European Association of Urological and European Society of Urology Imaging.The VI-RADS score can classify bladder cancer more accurately and provide guidance for clinicians in the treatment of patients with bladder cancer.This article reviews the research status and progress of VI-RADS in bladder cancer,VI-RADS parameters and the selection of the optimal cut-off value for the diagnosis of bladder cancer,and the combination of VI-RADS and radiomics,and looks forward to future research directions such as tumor size and tumor location on VI-RADS,aiming to provide reference for research in this field.